Keywords: دیسپیدمی; Blepharitis; Metabolic syndrome; Dyslipidaemia; Meibomian glands; Blefaritis; SÃndrome metabólico; Dislipidemia; Glándulas de Meibomio;
مقالات ISI دیسپیدمی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دیسپیدمی; Dislipidemia; Embarazo; Riesgo; Dyslipidaemia; Pregnancy; Risk;
Keywords: دیسپیدمی; Smoking; Alcohol consumption; Dyslipidaemia; Lipid profile; Chinese;
Keywords: دیسپیدمی; Dyslipidaemia; Hypercholesterolaemia; Hypertriglyceridaemia; Mediterranean diet; Sterols; Red yeast rice;
Keywords: دیسپیدمی; Metabolic syndrome; Homocysteine; Insulin resistance; Obesity; Dyslipidaemia; 3G; Gut, Grain and Greens; ALAT; alanine aminotransferase; ASAT; aspartate aminotransferase; Hcy; Homocysteine; SAH; s-adenosylhomocysteine; SAM; s-adenosylmethionine;
Keywords: دیسپیدمی; (3R,3â²R)-Astaxanthin (PubChem CID: 12358421); Astaxanthin; Carotenoid; Phaffia rhodozyma; Free-form astaxanthin; Dyslipidaemia; Triglycerides; Mechanisms of action;
Keywords: دیسپیدمی; Compliance; Lipoprotein apheresis; Familial hypercholesterolemia; Coronary heart disease; Dyslipidaemia;
Keywords: دیسپیدمی; Dyslipidaemia; Insulin resistance; Male infertility; Oligozoospermia;
Keywords: دیسپیدمی; Dyslipidaemia; Therapeutic lifestyle change; Educational course; Telephone call; Older people;
Keywords: دیسپیدمی; Escalas de riesgo cardiovascular; HTA; Diabetes; Dislipidemia; Tabaquismo; Cardiovascular risk scales; Arterial hypertension; Diabetes; Dyslipidaemia; Tobacco use;
Keywords: دیسپیدمی; Dyslipidaemia; Hepatic steatosis; High-fat diet; Hypertension; Obesity; Peroxisome proliferator-activated receptor;
Keywords: دیسپیدمی; Aneurisma; Aorta; Lumbalgia; DislipidemiaAneurysm; Aorta; Lumbar pain; Dyslipidaemia
Keywords: دیسپیدمی; Dyslipidaemia; Prevalence; Cardiovascular disease; Familial hypercholesterolaemia; Guidelines; Middle east;
Keywords: دیسپیدمی; Intrahepatic cholestasis of pregnancy; Lipoprotein lipase; Dyslipidaemia; Triglycerides; Lipid metabolism;
Keywords: دیسپیدمی; Tilapia; Freshwater clam; High-fat diet; Fatty streak; Dyslipidaemia; Hypocholesterolaemia; FCE(s); freshwater clam extract(s); FCW; hot-water extract of freshwater clam; FCWR; hydrolysate of clam residual meat; HDL; high-density lipoprotein-cholesterol;
Keywords: دیسپیدمی; AACE; American Association of Clinical Endocrinologists; ACC; American College of Cardiology; ACE; Africa Middle East Cardiovascular Epidemiological; AHA; American Heart Association; ASCVD; atherosclerotic cardiovascular disease; BMI; body mass index; CAD
Keywords: دیسپیدمی; Dolor torácico; Incidente cardiovascular; Dislipidemia; Guías de práctica clínica; Factores de riesgo cardiovascularChest pain; Cardiovascular incident; Dyslipidaemia; Clinical practice guidelines; Cardiovascular risk factors
Keywords: دیسپیدمی; Psychosis; Inflammation; Metabolic; C-reactive protein; Triglycerides; Cholesterol; Glucose; Insulin; Glycated haemoglobin; Dyslipidaemia;
Keywords: دیسپیدمی; atherosclerosis; cardiovascular risk; cerebrovascular disease; coronary artery disease; diabetes; dyslipidaemia; endothelial dysfunction; glycaemic memory; hypertension; peripheral arterial disease
Keywords: دیسپیدمی; Cancer; cardiovascular disease; diabetes; dyslipidaemia; heart failure; hyperinsulinaemia; hypertension; non-alcoholic steatohepatitis; sleep apnoea syndrome
Keywords: دیسپیدمی; Dyslipidaemia; Adipokine; Smooth muscle; Myometrium; Maternal obesity;
Keywords: دیسپیدمی; Type 1 diabetes; Atherosclerosis; Cardiovascular risk factors; Haemoglobin; Hypertension; Dyslipidaemia; Cholesterol HDL; Triglycerides; ObesityDiabetes tipo 1; Arteriosclerosis; Enfermedad cardiovascular; Factores de riesgo cardiovascular; Hemoglobina A1
Keywords: دیسپیدمی; Dyslipidaemia; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Safety; Statin;
Keywords: دیسپیدمی; Dyslipidaemia; Metabolic syndrome; NAFLD; Obesity; Type 2 diabetes mellitus;
Keywords: دیسپیدمی; Non-alcoholic fatty liver disease; Pathogenesis; Dyslipidaemia; Insulin resistance; Cardiovascular disease;
Keywords: دیسپیدمی; ACE; angiotensin converting enzyme; Akt; protein kinase B; DBP; diastolic blood pressure; GSK3; glycogen synthase kinase 3; HDL-C; high-density-lipoprotein cholesterol; HMGCoA; 3-hydroxy-3-methylglutaryl coenzyme A; LDL-C; low-density-lipoprotein choleste
Keywords: دیسپیدمی; Waist circumference; Waist-to-height ratio; Cardiovascular disease; Hypertension; Diabetes; Dyslipidaemia; Risk factors; Sub-Saharan Africa
Keywords: دیسپیدمی; Alopecia; Coronary heart disease; Dyslipidaemia; Hypertension; Insulin resistance; Meta-analysis;
Keywords: دیسپیدمی; Cholesteryl ester storage disease; Dyslipidaemia; Hepatomegaly; Lysosomal acid lipase deficiency; Wolman disease;
Keywords: دیسپیدمی; ABCA1; ATP binding cassette transporter A1; Actb; beta-actin; ApoA-I; apolipoprotein A-I; B2m; beta-2 microglobulin; Cyp2E1; cytochrome P450 2E1; FXR; farnesoid X receptor; Gapdh; glyceraldehyde-3-phosphate dehydrogenase; GLUT1; glucose transporter 1; HDL
Keywords: دیسپیدمی; Nutraceuticals; Dyslipidaemia; Cardiovascular diseases; Statins; Drug therapy;
Keywords: دیسپیدمی; Insulin resistance; Dyslipidaemia; Antipsychotic-naive first-episode psychosis schizophrenia; Psychopathology;
Keywords: دیسپیدمی; Metabolic syndrome; Hypertension; Dyslipidaemia; Nutraceuticals; Insulin resistance; ObesityACE, angiotensin converting enzyme; ALA, alpha-linoleic acid; AMPK, AMP-activated protein kinase; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; FPG, fasti
Keywords: دیسپیدمی; Cardiovascular disease; Diabetes mellitus; Dyslipidaemia; Simvastatin; Statins; HMG-CoA
Prise en charge des dyslipidémies, nouvelles recommandations
Keywords: دیسپیدمی; anomalie lipidique; dyslipidémie; recommandations; risque cardiovasculaire; statine; cardiovascular risk; dyslipidaemia; lipid disorder; recommendations; statin;
Facteurs de risque cardio-vasculaires en Algérie. Une analyse du sous-groupe de l'étude « Africa/Middle East Cardiovascular Epidemiological »
Keywords: دیسپیدمی; Facteur de risque cardio-vasculaire; FRCV; Algérie; Ãtude Africa/Middle East Cardiovascular Epidemiological; Ãpidémiologie; Dyslipidémie; Hypertension artérielle; Gestion de facteur de risque; Cardiovascular risk factors; CVRF; Africa/Middle East ca
Ethnic differences in plasma lipid levels in a large multiethnic cohort: The HELIUS study
Keywords: دیسپیدمی; Ethnicity; Lipid profile; Dyslipidaemia; Cardiovascular risk; HELIUS study;
Activity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal disease
Keywords: دیسپیدمی; Dyslipidaemia; Paraoxonase-1; HDL subclasses;
Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
Keywords: دیسپیدمی; Dyslipidaemia; Low-density lipoprotein cholesterol; Cardiovascular diseases; Comorbidity; Statins;
Control lipÃdico en pacientes con enfermedad coronaria del Área de Salud de Cáceres (España): estudio LIPICERES
Keywords: دیسپیدمی; Dislipidemia; Colesterol de las lipoproteÃnas de baja densidad; Riesgo cardiovascular; Objetivos cLDL; Dyslipidaemia; Low density lipoprotein cholesterol; Cardiovascular risk; LDLc targets;
Lipid control in patients with coronary artery disease in a healthcare area in Cáceres (Spain): LIPICERES study
Keywords: دیسپیدمی; Dyslipidaemia; Low density lipoprotein cholesterol; Cardiovascular risk; LDLc targets; Dislipidemia; Colesterol de las lipoproteÃnas de baja densidad; Riesgo cardiovascular; Objetivos cLDL;
Efecto de un programa de ejercicio fÃsico individualizado sobre el perfil lipÃdico en pacientes sedentarios con factores de riesgo cardiovascular
Keywords: دیسپیدمی; Ejercicio fÃsico; Dislipemia; Test de los 6 minutos; METS; Physical exercise; Dyslipidaemia; 6-minute test; METS;
Statin use and all-cause and cancer mortality: BioBank Japan cohort
Keywords: دیسپیدمی; Dyslipidaemia; Statins; Anti-cholesterol agents; Colon cancer; Kaplan-Meier estimate;
La protection cardiovasculaire du patient diabétique avec maladie rénale chronique et cas particulier de l'insuffisance rénale chronique terminale du sujet âgé
Keywords: دیسپیدمی; Diabète; Maladie rénale chronique; Morbi-mortalité; cardiovasculaire; Glycémie; BSRA; Pression artérielle; Dyslipidémie; Antiagrégant plaquettaire; Dialyse; Traitement conservateur; Score pronostique; Concertation; Diabetes; Chronic kidney disease;
Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia
Keywords: دیسپیدمی; Dyslipidaemia; Triglyceride; Statin; Combination therapy; SPPARMα; Pemafibrate; K-877;
Heat-killed Bifidobacterium animalis subsp. Lactis CECT 8145 increases lean mass and ameliorates metabolic syndrome in cafeteria-fed obese rats
Keywords: دیسپیدمی; Acc1; acetyl CoA carboxylase 1; Agrp; agouti-related protein; ANOVA; analysis of variance; Atgl; adipose triacylglycerol lipase; β-actin; actin beta; Ba8145; Bifidobacterium animalis subsp. lactis strain CECT 8145; Cart; cocaine and amphetamine-regulated
Effects of age, gender and statin dose on lipid levels: Results from the VOYAGER meta-analysis database
Keywords: دیسپیدمی; Age; Dyslipidaemia; Elderly; Gender; Statins; Women;
Dislipidemia y riesgo aterogénico en pacientes con lupus eritematoso sistémico
Keywords: دیسپیدمی; Lupus eritematoso sistémico; Dislipidemia; Índice aterogénicoSystemic lupus erythematosus; Dyslipidaemia; Atherogenic index
Dyslipidaemia and atherogenic risk in patients with systemic lupus erythematosus
Keywords: دیسپیدمی; Systemic lupus erythematosus; Dyslipidaemia; Atherogenic index; Lupus eritematoso sistémico; Dislipidemia; Índice aterogénico;
Direct analysis of VLDL by TOF-MS allows rapid definition of Apo E genotypes and facilitates characterisation of post translational changes
Keywords: دیسپیدمی; Apolipoprotein E; Dyslipidaemia; Whole protein mass spectrometry; Post translational modification; N-glycosylation;